| mRNA-based therapeutics: powerful and versatile tools to combat diseases S Qin, X Tang, Y Chen, K Chen, N Fan, W Xiao, Q Zheng, G Li, Y Teng, ... Signal transduction and targeted therapy 7 (1), 166, 2022 | 428 | 2022 |
| mRNA vaccines against SARS‐CoV‐2 variants delivered by lipid nanoparticles based on novel ionizable lipids K Chen, N Fan, H Huang, X Jiang, S Qin, W Xiao, Q Zheng, Y Zhang, ... Advanced functional materials 32 (39), 2204692, 2022 | 64 | 2022 |
| Manganese-coordinated mRNA vaccines with enhanced mRNA expression and immunogenicity induce robust immune responses against SARS-CoV-2 variants N Fan, K Chen, R Zhu, Z Zhang, H Huang, S Qin, Q Zheng, Z He, X He, ... Science Advances 8 (51), eabq3500, 2022 | 50 | 2022 |
| Lipid nanoparticle delivery system for mRNA encoding B7H3‐redirected bispecific antibody displays potent antitumor effects on malignant tumors C Huang, X Duan, J Wang, Q Tian, Y Ren, K Chen, Z Zhang, Y Li, Y Feng, ... Advanced Science 10 (3), 2205532, 2023 | 35 | 2023 |
| Sodium alginate coating simultaneously increases the biosafety and immunotherapeutic activity of the cationic mRNA nanovaccine X Duan, Y Zhang, M Guo, N Fan, K Chen, S Qin, W Xiao, Q Zheng, ... Acta Pharmaceutica Sinica B 13 (3), 942-954, 2023 | 21 | 2023 |
| A lipid-based LMP2-mRNA vaccine to treat nasopharyngeal carcinoma M Guo, X Duan, X Peng, Z Jin, H Huang, W Xiao, Q Zheng, Y Deng, N Fan, ... Nano Research 16 (4), 5357-5367, 2023 | 19 | 2023 |
| A novel heterologous receptor-binding domain dodecamer universal mRNA vaccine against SARS-CoV-2 variants S Qin, H Huang, W Xiao, K Chen, X He, X Tang, Z Huang, Y Zhang, ... Acta Pharmaceutica Sinica B 13 (10), 4291-4304, 2023 | 7 | 2023 |
| MHCI trafficking signal‐based mRNA vaccines strengthening immune protection against RNA viruses Y Zhang, S Zhai, S Qin, Y Chen, K Chen, Z Huang, X Lan, Y Luo, G Li, ... Bioengineering & Translational Medicine 10 (1), e10709, 2025 | | 2025 |
